Premium on Equity definition
Premium on Equity means the amount by which cash amounts received by Oncothyreon for a particular equity security exceed the Fair Market Value of such security.
Premium on Equity means the amount by which cash amounts received by ASLAN for a particular equity security exceed the Fair Market Value of such security.
Premium on Equity means in relation to the acquisition by any third party of any equity (or any form of security convertible into equity) in the Licensee or its Affiliates in connection with any Sub-License Agreement, the excess of actual purchase price paid for such equity over the fair market value of such equity. For clarity, if the fair market value of the equity is $8.00 and the amount paid by the third party is $10.00, the Premium on Equity is $2.00. Any dispute over the fair market value of the Licensee's stock shall be resolved through the dispute resolution procedure set out in clause 24.2;
More Definitions of Premium on Equity
Premium on Equity means the amount by which cash amounts received by a Party for a particular equity security exceed the Fair Market Value of such security.
Premium on Equity means the amount by which cash amounts received by CG or JT for a particular equity security exceed the Fair Market Value of such security. "Fair Market Value" of an equity security shall mean (i) if the equity security is traded on a National Exchange, then Fair Market Value shall equal the average closing sale price of a share of such equity security as reported on the National Exchange for the [*] trading days immediately preceding, and the [*] trading days including and following, the date CG or JT received payment for such security from the Marketing Distributor; (ii) if the equity security is not traded on a National Exchange, then Fair Market Value shall be determined on the basis of the common stock equivalents of such equity security, and shall equal the effective gross price per share of a common stock equivalent of CG or JT, as applicable, (subject to appropriate adjustments for stock splits, stock dividends, recapitalizations, reorganizations and combinations) in the last sales of equity securities by CG or JT to third parties other than the Marketing Distributor (but including sales to such other third parties made at the same time as the sale to the Marketing Distributor), in which the aggregate cash purchase price paid by such third parties exceeded [*] and in which at least [*] of the invested amount is from investors that are not pharmaceutical or biotechnology companies (or Affiliates thereof) and that have not previously invested in CG or JT (respectively) and have not entered into a collaboration or contractual arrangement with CG or JT (respectively). For such purposes, "National Exchange" means the New York Stock Exchange, the American Stock Exchange, any national market system (including without limitation the Nasdaq National Market), or the European or Japanese equivalent of such an exchange or market system.
Premium on Equity means the amount by which cash amounts received by ABX or its Wholly-Owned Subsidiary for shares in such company exceed Fair Market Value of such shares. "Fair Market Value" or an equity security shall mean (i) if the equity security is traded on a National Exchange, then Fair Market Value shall equal the average closing sale price of a share of such equity security as reported on the National Exchange for each of the thirty (30) trading days immediately preceding the date ABX received payment for such security from the Sublicensee; (ii) if the equity security is not traded on a National Exchange, then Fair Market Value shall be determined on the basis of the common stock equivalents of such equity security, and shall equal the effective gross price per share of a common stock equivalent of ABX (subject to appropriate adjustments for stock splits, stock dividends, recapitalizations, reorganizations and combinations) in the last sales of equity securities by ABX to third parties other than the Sublicensee (but including sales to such other third parties made at the same time as the sale to the Sublicensee), in which the aggregate cash purchase price paid by such third parties exceeded Three Million Dollars ($3,000,000) and in which at least fifty percent (50%) of the invested amount is from investors that are not pharmaceutical or biotechnology companies (or Affiliates thereof) and that have not previously invested in ABX and have not entered into a collaboration or contractual arrangement with ABX. For such purposes, "National Exchange" means the New York Stock Exchange, the American Stock Exchange, any national market system (including without limitation the Nasdaq National Market), or the European equivalent of such an exchange or market system.
Premium on Equity means the amount by which amounts received by Somantis for a particular equity security exceed the fair market value of such security. Net Sales Value The [CONFIDENTIAL TREATMENT REQUESTED] price of Royalty-bearing Products sold by Somantis or its Affiliates to independent third parties in arm’s length transactions exclusively for money or, where the sale is not at arm’s length, the price that would have been so [CONFIDENTIAL TREATMENT REQUESTED] if it had been at arm’s length, after deduction of normal trade discounts actually granted and any credits actually given and, provided the amounts are separately charged on the relevant [CONFIDENTIAL TREATMENT REQUESTED], any costs of packaging, insurance, carriage and freight, any value added tax or other sales tax, and any import duties or similar applicable government levies. Parties The School of Pharmacy and Somantis, and “Party” shall mean either of them. Patents Any and all of the patents and patent applications referred to in Schedule 1, including any continuations, continuations in part, extensions, reissues, divisions, and any patents, supplementary protection certificates and similar rights that are based on or derive priority from the foregoing. Research Collaboration Agreement A research collaboration agreement between The School of Pharmacy and Somantis under which Somantis shall fund further research by The School of Pharmacy on the invention(s) disclosed in the Patents on terms acceptable to both parties.
Premium on Equity means the amount by which amounts received by Somantis for a particular equity security exceed the fair market value of such security. Net Sales Value The [CONFIDENTIAL TREATMENT REQUESTED] price of Royalty-bearing Products sold by Somantis or its Affiliates to independent third parties in arm's length transactions exclusively for money or, where the sale is not at arm's length, the price that would have been so [CONFIDENTIAL TREATMENT REQUESTED] if it had been at arm's length, after deduction of normal trade discounts actually granted and any credits actually given and, provided the amounts are separately charged on the relevant [CONFIDENTIAL TREATMENT REQUESTED], any costs of packaging, insurance, carriage and freight, any value added tax or other sales tax, and any import duties or similar applicable government levies.